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INTRODUCTION
If  left untreated, ureteropelvic junction obstruction 
(UPJO) can lead to hydronephrosis and progressive 
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impairment of renal function. With success rates exceeding 
98%, Anderson-Hynes dismembered pyeloplasty has 
become the gold standard for treating primary UPJO [1]. 
Although pyeloplasty failure is uncommon, it does occur, 
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requiring secondary surgical intervention [2,3]. Currently, 
several studies have reported on the high success rate 
of  redo pyeloplasty [4,5]. However, to our knowledge, 
the factors af fecting functional outcomes after redo 
pyeloplasty have not yet been reported. Accordingly, the 
aim of  this retrospective study was to evaluate changes 
in dif ferential renal function (DRF), as a functional 
outcome, in children who underwent redo pyeloplasty for 
the management of failed pyeloplasty and to outline the 
factors associated therewith. Our observations may help to 
improve functional outcomes of redo pyeloplasty. 
MATERIALS AND METHODS
With approval from the Institutional Review Broad 
of Severance Hospital (4-2014-0081), medical records were 
obtained from a database of patients who had undergone 
redo pyeloplasty between January 2002 and November 
2010 at Severance Hospital in Seoul, Korea. During this 
period, a total of 21 children underwent redo pyeloplasty 
by a single surgeon (S.W.H.) at Sevrance Hospital. The 
initial pyeloplasties were performed at our institution in 
11 children, and the remaining procedures were performed 
at other institutions. 
Information on preoperative DRF and renal cortical 
thickness (RCT) was not available for 3 patients who 
had undergone renal scintigraphy or ultrasound at other 
institutions, and these patients were excluded from the 
analysis. Finally, a total of  18 patients were enrolled in 
this study.
Failure of  initial pyeloplasty was judged by either 
obstructive symptoms or signs. The decision to perform 
redo pyeloplasty depended on the presence of  symptoms 
(e.g., urinary tract infection, f lank pain), functional 
loss (deterioration of  DRF of  more than 5%), and an 
aggravated obstruction pattern on a renogram or a huge 
urinoma.
The patients were followed up postoperatively by use 
of serial ultrasound and renal scintigraphy for evaluating 
long-term functional outcomes. Follow-up ultrasound was 
performed at 4 to 6 weeks after the operation and was then 
repeated every 1 to 6 months thereafter, according to the 
results of a previous study. The degree of hydronephrosis 
was graded from 0 to 4 according to the Society for Fetal 
Urology (SFU) classification scheme [6]. Renal scintigraphy 
was performed 6 months after the operation and was 
repeated if needed. 
DRF was assessed by using either 99mTc-dimercapto-
succinic acid or 99mTc-mercaptoacetyltriglycine. RCT was 
measured in the sagittal plane at the level of  the mid-
kidney, as described by Moghazi et al. [7]. The measure ment 
was obtained over the medullary pyramid, perpendicular 
to the capsule, and as the shortest distance from the base 
of the medullary pyramid to the renal capsule. 
Statistical comparisons of  continuous variables in 
patient demographics were carried out by using the Mann-
Whitney U-test. Categorical variables were calculated by 
using Fisher exact test. The Wilcoxon signed rank test 
was used for paired comparisons of before and after the 
operation. PASW Statistics ver. 18.0 (SPSS Inc., Chicago, IL, 
USA) was used for statistical analyses. All p-values less 
than 0.05 were considered statistically significant.
RESULTS
The characteristics of  the patients enrolled in this 
study af ter initial pyeloplasty are summarized in 
Table 1. All patients showed at least persistent or mild 
increases of  hydronephrosis on ultrasound, with results 
on postoperative renal scintigraphy consistent with 
an obstruction. The mean interval between operations 
(between initial pyeloplasty and redo pyeloplasty) was 
13.67±10.33 months. The causes of redo pyeloplasty included 
persistent obstruction on renography related to worsening 
hydronephrosis or a huge urinoma on ultrasound or the 
development of symptomatic obstruction, such as urinary 
tract infection and recurrent pain. With a mean follow-up 
period of  44.83±28.86 months, unilateral obstruction was 
resolved in 18 patients after redo pyeloplasty.
Redo pyeloplasty was performed in 2 patients owing 
to a huge urinoma. Both showed increased drain output 
and a huge urinoma on an ultrasound after the first 
pyeloplasty. Thus, we first attempted ureteral stent inser-
tion, which failed. Within about 1 week, redo pyeloplasty 
was performed.
A stented redo pyeloplasty was performed in 11 
patients. Whether to use a stent was determined on the 
basis of  viability and fibrotic changes in the UPJ, as 
well as the presence of  perinephric tissue. Stents were 
removed after a mean of 29.6±19.1 days. Dismembered-type 
pyeloplasty was performed in 13 patients. 
1. Postoperative DRF
DRF on renal scintigraphy worsened after the initial 
pyeloplasty in 6 patients, who showed deterioration of 
renal function (decrease of more than 5%); was stable in 11 
patients; and slightly increased in 1 patient. The mean DRF 
of  diseased kidneys before and after initial pyeloplasty 
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was 45.77%±6.05% and 38.72%±15.44%, respectively. At 
approximately 6 months after redo pyeloplasty, the mean 
DRF increased to only 40.50%±15.12%, a difference that 
was not significant. After redo pyeloplasty, prevention 
of  further functional deterioration was recorded in two-
thirds of the patients but not in the remaining one-third 
(Fig. 1).
2. Change in hydronephrosis grade
Before redo pyeloplasty, 14 patients were hydronephrosis 
grade 4 and the others were hydronephrosis grade 3. 
When we evaluated hydronephrosis grade with serial 
ultra sound after redo pyeloplasty, all patients showed an 
improve ment in hydronephrosis grade compared with that 
before redo pyeloplasty. 
Table 1. Characteristics of patients who underwent redo pyeloplasty
No. Gender Laterality
Age 
(mo)
Follow-up 
duration between 
operations (mo)
Cause of redo 
pyeloplastya
DRF
Hydronephrosis 
grade (SFU)
Redo operation
Initial Preb Postb Preb Postb Type Stent
1 F Left 13 13 4 45 46 51 3 3 Dismembered Yes
2 F Left 196 24 4 52 37 36 4 2 Dismembered Yes
3 M Left 18 7 2 47 24 24 4 3 Dismembered Yes
4 M Left 17 12 2 51 29 32 3 2 Dismembered Yes
5 M Left 22 20 4 41 36 33 3 2 Dismembered Yes
6 M Left 16 8 2 48 48 50 4 2 Nondismembered No
7 M Right 31 6 4 48 48 51 4 3 Dismembered No
8 M Left 37 24 4 43 53 59 3 2 Nondismembered Yes
9 M Left 23 11 4 45 36 42 4 3 Dismembered No
10 M Left 10 9 2 41 6 9 4 2 Non-dismembered No
11 M Left 125 7 3 51 49 53 4 2 Nondismembered No
12 M Left 2 0 1 57 57 56 4 2 Dismembered Yes
13 M Left 54 27 4 31 38 40 4 3 Dismembered Yes
14 M Left 120 41 3 52 53 51 4 3 Dismembered No
15 M Right 70 10 3 39 1 6 4 2 Nondismembered Yes
16 F Left 114 5 3 41 41 41 4 2 Dismembered Yes
17 M Left 108 0 1 47 47 51 4 2 Dismembered Yes
18 M Left 23 22 3 45 48 44 4 3 Dismembered No
DRF, differential renal function; SFU, Society for Fetal Urology; UTI, urinary tract infection.
a:1, huge urinoma; 2, UTI; 3, flank pain; 4, persistent obstruction on renography and worsening hydronephrosis on ultrasound. b: pre, before redo 
pyeloplasty; post, after redo pyeloplasty.
Fig. 1. Changes in differential renal function (DRF) after initial and redo pyeloplasty on renal scintigraphy. (A) Patients that final DRF were not decreased 
more than 5% of the initial DRF. (B) Patients that final DRF were decreased more than 5% of the initial DRF.
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3. Comparison of patients grouped according to 
decrease in DRF of more than 5%
We divided all 18 patients into two groups according 
to change in DRF. Six patients showed a decrease of 
more than 5% DRF compared with initial DRF. The 
mean ages were 55.50±72.1 months in the decrease in DRF 
group and 55.50±47.15 months in the no decrease in DRF 
group (p=0.616). The mean follow-up duration between 
operations was 13.66±12.40 months in the decrease in DRF 
group and 13.66±6.77 months in the no decrease in DRF 
group (p=0.682). The mean DRF before initial pyeloplasty 
was 45.16%±5.60% in the decrease in DRF group and 
was not significantly different from that (46.08%±6.41%) 
in the no decrease in DRF group (p=0.604). Gender, 
hydronephrosis grade, and operation type (dismembered 
vs. nondismembered; stented vs. unstented) were not 
statistically different between the two groups.
dDRF was calculated as the difference in DRF between 
before and after initial pyeloplasty. In the decrease in 
DRF group, the mean dDRF was –23.00%±12.31%. In the no 
decrease in DRF group, the mean dDRF was 0.91%±4.62%. 
In the decrease in DRF group, DRF was significantly 
decreased between before and after initial pyeloplasty 
(p=0.028); in the no decrease in DRF group, the difference 
was not signif icant (p=0.397). Overall, dDRF dif fered 
significantly between the two groups (p<0.001). 
dRCT was calculated as the difference in RCT between 
before and after initial pyeloplasty. In the decrease in 
DRF group, the mean dRCT (–3.56±2.9 mm) was higher 
than that in the no decrease in DRF group (–0.41±0.27 
mm), a significant difference between the two groups 
(p<0.001).
Additionally, we calculated rDRF as the difference 
in DRF between before and after redo pyeloplasty, as 
a reflection of  the level of  recovery of  DRF after redo 
pyeloplasty. In the decrease in DRF group, the mean rDRF 
was 1.16%±2.99%. In the no decrease in DRF group, it was 
2.08%±3.23%. The difference in rDRF between the two 
groups was not significant (p=0.541) (Table 2).
Finally, we noted a significant positive correlation 
between dRCT and dDRF (differences between before 
and after the initial operation; p<0.001; R2 linear=0.716). 
Patients without deterioration of  renal function showed 
almost no change in RCT. Meanwhile, patients with a 
decline in DRF of more than 5% showed greater decreases 
in RCT (Fig. 2).
4. Complications with redo pyeloplasty
During the follow-up period, we observed one compli-
cation associated with redo pyeloplasty. The patient 
Table 2. Comparison of patients grouped according to decrease in differential renal function (DRF) of more than 5% (initial vs. final)
Variable Group 1 (n=12) Group 2 (n=6) p-value
Gender (M : F) 10 : 2 5 : 1 1.000
Age at operation (mo) 55.50±47.15 55.50±72.15 0.574
Follow-up duration between operations (mo) 13.66±6.77 13.66±12.40 0.639
Preoperative hydronephrosis grade (SFU) 0.569
3 2 2
4 10 4
Type of redo pyeloplasty 1.000
Dismembered 9 4
Nondismemebered 3 2
Use of stent after redo pyeloplasty 0.316
Yes 6 5
No 6 1
DRF before initial pyeloplasty (%) 46.08±6.41 45.16±5.60 0.604
rDRFa (%) 2.08±3.23 1.16±2.99 0.541
dDRFb (%) 0.91±4.62 –23.00±12.31* <0.001
dRCTc (mm) –0.41±0.27 –3.56±2.94 <0.001
Values are presented as mean±standard deviation.
Group 1, patients in whom final DRF did not decrease by more than 5% of the initial DRF; group 2, patients in whom final DRF decreased by more 
than 5% of the initial DRF; RCT, renal cortical thickness.
A p-value was analyzed by Mann Whitney U-test , Fisher exact test. 
a: Difference in DRF between before and after redo pyeloplasty. b: Difference in DRF between before and after initial pyeloplasty. c: Difference in 
RCT between before and after initial pyeloplasty. *: p<0.05 by Wilcoxon signed rank test.
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showed no change in hydronephrosis grade (SFU grade 
3) and reported experiencing f lank pain af ter redo 
pyeloplasty. Therefore, we performed double J stent 
insertion at 1 month after the redo operation. We removed 
the stent after 1 month and after all symptoms had 
disappeared. 
DISCUSSION
Since Anderson and Hynes reported on the f irst 
successful dismembered pyeloplasty in 1891, many advances 
have been made in the surgical management of  UPJO. 
However, the basic surgical principles have remained 
largely the same, including the meticulous preservation of 
the ureteral blood supply, construction of a widely patent 
and watertight anastomosis, and careful tissue handling. 
These principles have allowed dismembered pyeloplasty to 
be successful in relieving UPJO in up to 98% of cases [1]. 
Even when patients are optimally managed, however, 
pyeloplasty fails in a small but steady proportion of 
patients. Several treatment approaches exist for secondary 
UPJO after failed pyeloplasty. Among them, redo pye-
loplasty, by use of  both open and minimally invasive 
techniques, appears to be the most effective, with success 
rates higher than 90% among pediatric patients [8-11]. 
However, no reports yet exist concerning changes in renal 
function after redo pyeloplasty. Also, factors that can 
inform the functional outcome of redo pyeloplasty remain 
undetermined. Therefore, in the present study, we set 
out to evaluate changes in DRF and RCT by use of serial 
renal scintigraphy and ultrasound. In doing so, we found 
that, after redo pyeloplasty, DRF on renal scintigraphy 
was similar to that after failed pyeloplasty, reflecting the 
difficulties of recovering initial renal function. 
In previous studies, researchers noted that DRF 
significantly improved in children with immediate or 
delayed pyeloplasty [12,13]. On the other hand, another 
study reported that Anderson-Hynes pyeloplasty had 
no effect on renal function after surgery and that the 
increase in renal function at follow-up in infants might 
be attributable to their normal growth potential [14]. In 
light of  our results, patients should not expect dramatic 
improvements in renal function after redo pyeloplasty. 
Nonetheless, prior to conducting this study, we assu-
med that recovery of renal function after redo pyeloplasty 
would ref lect preservation or improvement in initial 
DRF. However, when we compared two groups of patients 
divided according to a decrease in DRF of  more than 
5% of initial DRF, dDRF was shown to be a factor that 
significantly contributed to functional recovery after 
redo pyeloplasty in pediatric patients. We discerned this 
to mean that severe reductions in renal function after 
an initial surgery may greatly affect the likelihood of 
recovering initial renal function after redo pyeloplasty. 
For detecting severely reduced DRF after a failed 
pyeloplasty, we attempted to assess RCT as another fac-
tor of  recoverability of  renal function. Herein, dRCT 
was shown to be a significant factor that affected the 
functional outcome of redo pyeloplasty. Previously, Harraz 
et al. [15] reported that, after the relief of obstruction, there 
is a tendency for renal function to recover, irrespective 
of  nephron mass, as determined by cortical thickness. 
They speculated that healthy nephrons might explain 
the ability of the kidneys to recover. Other investigators 
have also reported RCT as a powerful predictor of renal 
function [16,17]. In connection with these reports, we found 
a positive correlation between dDRF and dRCT in patients 
who experienced a failed pyeloplasty. Accordingly, we 
think that dRCT could be a predictor of dDRF in patients 
scheduled to undergo redo pyeloplasty, which may help 
physicians in predicting the likelihood of recovering initial 
renal function thereafter. Although RCT on ultrasound 
could present bias in the outcome measure, standardized 
measurement of  RCT with serial ultrasound would be 
helpful to determine the benefits of a secondary operation. 
Additionally, we evaluated changes in hydronephrosis 
after redo pyeloplasty. Most patients showed an improve-
ment in hydronephrosis after redo pyeloplasty, although 
normalization was rare. In primary pyeloplasty, Park et 
al. [18] reported that both symptomatic cases and delayed 
improvements in hydronephrosis (i.e., up to 6 months) 
were identified as risk factors for lack of normalization. 
Fig. 2. Correlation between change in renal cortical thickness (dRCT) 
and change in differential renal function (dDRF) from before to after 
initial pyeloplasty. 
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These factors may reflect a reduced resilience of  the 
pelvis. Therefore, the possibility of  normalization after 
redo pyeloplasty seems to be lower than that after initial 
pyeloplasty.
Nevertheless, we must acknowledge the limitations 
of  our report, including the inherent drawbacks of  the 
retrospective design and the lack of  bias control. Also, 
the accuracy of using renal scintigraphy as a measure of 
renal function is in question [19,20]. Although large-scale 
studies are needed to draw more definitive conclusions, 
these are difficult owing to the very low failure rate of 
pyeloplasty. As strengths of our study, however, the data 
in our series were collected from patients who underwent 
redo surgeries performed by a single surgeon and included 
many variables that might predict DRF recoverability 
after redo pyeloplasty. Accordingly, we believe that our 
study is important to establishing the concept of a renal 
functional outcome for predicting improvement after redo 
pyeloplasty. Such a concept would better equip physicians 
for proper counseling of patients before surgery and for 
making successful surgical decisions.
CONCLUSIONS
Redo pyeloplasty should be considered in cases of 
failed pyeloplasty in order to preserve renal function 
and to of fer relief  f rom symptoms. In patients who 
underwent redo pyeloplasty, dDRF and dRCT were 
shown to be factors affecting the functional outcomes of 
this procedure. Meanwhile, in patients who show severe 
deteriorations in DRF or decreases in RCT after initial 
pyeloplasty, recovery of initial DRF after redo pyeloplasty 
may be difficult. Therefore, redo pyeloplasty should be 
performed before severe deterioration of DRF or decreases 
in RCT.
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EDITORIAL COMMENT
Reoperation is a psychologically large burden on the 
operator, and the reoperation itself is more difficult than 
the initial operation because of  the adhesive surgical 
field and poor tissue condition of  the renal pelvis and 
ureter. Complicated surgical techniques such as f lap 
surgery or ureterocalicostomy should be applied in some 
cases. Owing to the rarity of reoperation cases, knowledge 
about redo pyeloplasty has usually been gained through 
the experience of an individual surgeon. Thus, this study 
is valuable and very informative for showing detailed 
clinical data [1]. I would like to make some comments in 
the aspect of clinical practice.
First, after initial pyeloplasty, the postoperative result 
is not as simple and conclusive as “surgical failure.” 
Sometimes, it is not easy for the surgeon to decide on 
reoperation. Discrepancies may exist in the imaging 
studies between the sonographic findings and excretion 
and renal function in the diuretic renogram. Some patients 
show delayed excretion despite moderate improvement 
of  hydronephrosis. In particular, postoperative transient 
hydronephrosis could be present and a “wait-and-see” 
approach is considered because most cases improve 
spontaneously. In case No. 1, differential renal function 
(DRF) was 46% and hydronephrosis was grade 3; thus, the 
“wait-and-see” approach could be considered if the patient 
did not show flank pain or urinary tract infection. 
Second, in a very poorly functioning kidney, maybe as 
the result of obstruction or infection, is it meaningful to 
perform redo pyeloplasty? We should not expect functional 
improvement by the relief of obstruction. In cases No. 10 
and 15, the DRF was only 1% and 6%, respectively; thus, 
functional recovery was not expected in these cases [2]. In 
my experience, functional improvement can be achieved 
only in the case of an acute high-grade obstruction. Double 
J stenting and follow-up evaluation of functional change 
could be an option to predict functional restoration after 
the operation. 
Finally, the author concluded that recovery of  DRF 
after redo pyeloplasty is difficult in patients who show 
severe deteriorations in DRF or a decrease in renal 
cortical thickness after the initial pyeloplasty. The title 
of  this article implicates the author’s conclusive mind 
that delayed redo pyeloplasty fails to recover lost renal 
function. The authors suggest that one should not 
hesitate to perform reoperation in cases of postoperative 
findings such as sonographic changes and loss of  renal 
function. Although it is not easy for surgeons to recom-
mend reoperation during follow-up, it is worse to delay 
the decision for reoperation in cases showing definite 
deterioration. Eventually, the deterioration causes super-
imposed urinary tract infection and flank pain and finally 
leads to decreased renal function. 
We acknowledge the limitations of  this study, especi-
ally the unaccounted for compounding surgical factors 
such complicated surgical field conditions and the location 
and degree of stricture, which were unavoidable owing to 
the study design. Despite this limitation, we believe that 
these data provide us deep insight into redo pyeloplasty. 
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